期刊文献+

47例血管母细胞瘤临床病理特征分析 被引量:1

Analysis of clinicopathologic features of hemangioblastomas in 47 cases
原文传递
导出
摘要 目的分析血管母细胞瘤(HB)临床病理特征。方法回顾性分析47例HB患者HE染色病理特征及SP法染色相关免疫组化标志物表达。结果肿瘤组织表现为特征性间质细胞及其之间丰富的毛细血管,血管壁衬覆扁平内皮细胞。肿瘤组织多阳性表达CD34、CD31、Vim、D2-40、NSE、S100、CD56、EGFR和VEGF,多阴性表达EMA、CK和GFAP。散发性HB患者免疫阳性表达率与VHL相关性HB患者相仿(P>0.05)。结论结合HE染色病理特征及相关标志物表达有助于诊断HB。 Objective To analyze the clinicopathologic features of hemangioblastomas(HB).Methods Clinicopathologic features(HE stainning)and expressions of related immunohistochemical markers(SP method)of 47 HB patients were retrospectively analyzed.Results HB tissues showed a typical type of stroma cells with rich capillaries lined by flattened endothelial cells.Majority of HB tissues positively expressed CD34,CD31,Vim,D2-40,NSE,S100,CD56,EGFR and VEGF,but negatively expressed EMA,CK and GFAP.The positive expression rate of immune markes in sporadic HB patients was similar to that in von Hippel-Lindau(VHL)syndrome-related HB patients(P〉0.05).Conclusion Combined analysis of HE stainning pathological features and the expressions of related markers can be helpful in the diagnosis of HB.
出处 《江苏医药》 CAS 2015年第1期63-65,F0002,共4页 Jiangsu Medical Journal
关键词 血管母细胞瘤 症状 治疗方法 Hemangioblastomas
  • 相关文献

参考文献2

二级参考文献23

  • 1张福林,汪寅,陈宏,徐启武,陈衔城,周范民,黄峰平,周良辅.5109例中枢神经系统肿瘤WHO新分类统计分析[J].临床与实验病理学杂志,2004,20(6):688-691. 被引量:9
  • 2Louis DN, Ohgaki H, Wiestler OD, et al. WHO classification of tumours of the central nervous system. Lyon : IARC Press, 2007 : 184-186,215-217.
  • 3Leung RS, Biswas SV, Duncan M, et al. Imaging features of yon Hippel-Lindau disease. Radiographics, 2008, 28( 1 ) :65-79.
  • 4Conway JE, Chou D, Clatterbuck RE, et al. Hemangioblastomas of the central nervous system in van Hippel-Lindau syndrome and sporadic disease. Neurosurgery, 2001,48 ( 1 ) :55-62.
  • 5Sofa S, Ueki K, Saito N, et al. Incidence of yon Hippel-Lindau disease in hemangioblastoma patients: the University of Tokyo Hospital experience from 1954-1998. Acta Neurochir (Wien), 2001, 143(9) :893-896.
  • 6Melmon KL,Rosen SW. Lindau's disease. Review of the literature and study of a large kindred. Am J Med, 1964,36:595-617.
  • 7Richard S, Graft J, Lindau J, et al. Von Hippel-Lindau disease. Lancet, 2004, 363(9416):1231-1234.
  • 8Richard S, Campello C, Taillandier L, et al. Haemangioblastoma of the central nervous system in yon Hippel-Lindau disease. French VHL Study Group. J Intern Med, 1998, 243 (6):547- 553.
  • 9Ishizawa K, Komori T, Hirose T. Stromal cells in hemangioblastoma: neuroeetodermal differentiation and morphological similarities to ependymoma. Pathol Int,2005,55 (7) :377-385.
  • 10Roy S, Chu A, Trojanowski JQ, et al. D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas. Acta Neuropathol, 2005, 109(5) :497-502.

共引文献31

同被引文献9

  • 1DN Louis, H Ohgaki, OD Wiestler, et al. The 2007 WHO classifica- tion of tumours of the central nervous system [ M ]. Lyon : Interna- tional Agency for Research on Cancer (IARC) ,2007 : 184 - 186.
  • 2Li Z, Feng T, Teng H, et al. Suprasellar hemangioblastoma without yon Hippel - Lindau disease: a case report and literature review [ J]. Int J Clin Exp Patho1,2015,8 ( 6 ) :7553 - 7558.
  • 3Kim H, Park IS, Jo KW. Meningeal supratentorial hemangioblastoma in a patient with von hippel - lindau disease mimicking angioblastic menigioma[ J ]. J Korean Neurosurg Soc,2013,54 (5) :415 - 419.
  • 4Li WQ, Wang X, Zhong NZ, et al. Spinal hemangioblastoma com- bined with pilocytic astrocytoma[ J]. Neurosciences ,2015,20 ( 3 ) : 280 - 284.
  • 5Cheng HX, Chu SG, Xu Qw, et al. A spinal tumor showing mixed features of ependymoma and hemangioblastoma: a case report and literature review[ J ]. Brain Tumor Patho1,2015,32 (2) : 112 - 118.
  • 6PC Burger, BW Scheithaner, BKK - DeMasters, et al. Neuropatholo- gy [ M ]. Salt Lake City: AMIRSYS ,2014:270 - 277.
  • 7Hoang MP, Amirkhan RH. Inhibin - alpha distinguishes hemangio- blastoma from clear cell renal cell carcinoma [ J ]. Am J Surg Pathol,2003 ,27 :1152 - 1156.
  • 8Roy S, Chu A, Trejanowski JQ, et al. D2 -40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish heman- gioblastomas from renal cell carcinomas [ J ]. Acta Neuropathol, 2005,109 ( 5 ) :497 - 502.
  • 9李俊芝,古丽那尔.阿布拉江,张巍.血管母细胞瘤50例临床病理分析[J].新疆医科大学学报,2010,33(11):1307-1309. 被引量:2

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部